Found: 24
Select item for more details and to access through your institution.
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 4, p. 983, doi. 10.1093/cid/ciad506
- By:
- Publication type:
- Article
Impact of Share 35 liver transplantation allocation in Australia and New Zealand.
- Published in:
- Clinical Transplantation, 2024, v. 38, n. 1, p. 1, doi. 10.1111/ctr.15203
- By:
- Publication type:
- Article
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study.
- Published in:
- Journal of the International AIDS Society, 2023, v. 26, n. 9, p. 1, doi. 10.1002/jia2.26168
- By:
- Publication type:
- Article
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg‐positive chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 5, p. 509, doi. 10.1111/apt.17299
- By:
- Publication type:
- Article
Atopy and allergy following solid organ transplantation: A 15‐year experience.
- Published in:
- Journal of Paediatrics & Child Health, 2023, v. 59, n. 3, p. 537, doi. 10.1111/jpc.16349
- By:
- Publication type:
- Article
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B.
- Published in:
- Antiviral Therapy, 2022, v. 27, n. 3, p. 1, doi. 10.1177/13596535221093856
- By:
- Publication type:
- Article
Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Molecular Phylogenetics of Hepatitis D Virus in New Zealand and the Implications for Pacific Island Countries.
- Published in:
- Intervirology, 2021, v. 64, n. 2, p. 102, doi. 10.1159/000513685
- By:
- Publication type:
- Article
Feasibility and outcomes of a hepatitis C screening programme in community pharmacies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 11, p. e2022388, doi. 10.1001/jamanetworkopen.2020.22388
- By:
- Publication type:
- Article
HBV variants are common in the 'immune‐tolerant' phase of chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 10, p. 1061, doi. 10.1111/jvh.13318
- By:
- Publication type:
- Article
Chronic hepatitis B infection-an unmet medical need in New Zealand 35 years after universal neonatal vaccination.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Increasing burden of advanced hepatocellular carcinoma in New Zealand-the need for better surveillance.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0222259
- By:
- Publication type:
- Article
Patient‐reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication.
- Published in:
- Liver International, 2019, v. 39, n. 10, p. 1837, doi. 10.1111/liv.14171
- By:
- Publication type:
- Article
Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2019, v. 39, n. 8, p. 1468, doi. 10.1111/liv.14113
- By:
- Publication type:
- Article
Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 1, p. 40, doi. 10.1111/jgh.14457
- By:
- Publication type:
- Article
Long‐term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation.
- Published in:
- JGH Open, 2018, v. 2, n. 6, p. 288, doi. 10.1002/jgh3.12086
- By:
- Publication type:
- Article
Hepatitis B virus-related hepatocellular carcinoma presenting at an advanced stage: is it preventable?
- Published in:
- 2018
- By:
- Publication type:
- journal article
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg‐positive chronic hepatitis B.
- Published in:
- Liver International, 2018, v. 38, n. 10, p. 1760, doi. 10.1111/liv.13716
- By:
- Publication type:
- Article
The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand.
- Published in:
- Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 2, p. 434, doi. 10.1111/jgh.13082
- By:
- Publication type:
- Article
Predicting outcome in patients with cirrhosis following acute decompensation: Can we do better?
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Liver Resection for Hepatocellular Carcinoma in a Hepatitis B Endemic Area.
- Published in:
- World Journal of Surgery, 2007, v. 31, n. 9, p. 1775, doi. 10.1007/s00268-007-9069-4
- By:
- Publication type:
- Article